Pia Burman

Medicine & Life Sciences

1. Acromegaly 59%
2. Addison Disease 15%
3. Adrenal Insufficiency 29%
4. Adrenal Rest Tumor 14%
5. Adrenalectomy 11%
6. aryl hydrocarbon receptor-interacting protein 13%
7. ATR-X syndrome 13%
8. Body Composition 19%
9. Brain Neoplasms 14%
10. Cabergoline 17%
11. Congenital Adrenal Hyperplasia 10%
12. Corticotrophs 24%
13. Cortisone 10%
14. Craniopharyngioma 11%
15. Cross-Over Studies 11%
16. Cushing Syndrome 12%
17. Cyclin-Dependent Kinase Inhibitor p27 11%
18. Dopamine Agonists 10%
19. Endocrinology 22%
20. Fat Necrosis 11%
21. Growth Hormone 59%
22. Hereditary Nonpolyposis Colorectal Neoplasms 10%
23. Hormone Replacement Therapy 18%
24. Hydrocortisone 36%
25. Hypopituitarism 20%
26. Incidence 12%
27. Insulin-Like Growth Factor I 27%
28. Langerhans Cell Histiocytosis 10%
29. Meta-Analysis 17%
30. metomidate 15%
31. Morbidity 11%
32. Mortality 15%
33. Multiple Endocrine Neoplasia 10%
34. Mutation 11%
35. Nelson Syndrome 12%
36. Neoplasms 18%
37. pegvisomant 25%
38. Pituitary ACTH Hypersecretion 62%
39. Pituitary Neoplasms 100%
40. Placebos 15%
41. Prolactinoma 23%
42. Quality of Life 12%
43. Radiotherapy 19%
44. Safety 15%
45. Somatostatin 19%
46. somatostatin receptor 5 13%
47. Sweden 15%
48. Systematic Reviews 11%
49. Temozolomide 34%
50. Therapeutics 23%